What is Medpace Holdings Inc Annual Revenue?

Medpace Holdings Inc Annual Revenue rose 11.84%, in the last year to $2,109.05 M. Its sector's average revenue growth for the last fiscal year was 1.09%.

What is Medpace Holdings Inc Annual Net Profit?

Medpace Holdings Inc Annual Net Profit rose 42.99% in the last year to $404.39 M. Its sector's average net profit growth for the last fiscal year was -17.35%.

What is Medpace Holdings Inc Price to Earning Ratio?

Medpace Holdings Inc Price to Earning Ratio is 21.6, lower than its sector PE ratio of 29.66.

What is Medpace Holdings Inc Stock Price?

Medpace Holdings Inc Stock Price fell 22.31% and underperformed its sector by 32.33% in the past year.

What is Medpace Holdings Inc Quarterly Revenue?

Medpace Holdings Inc Quarterly Revenue rose 7.66% YoY to $536.59 M. Its sector's average revenue growth YoY for the quarter was 3.41%.

What is Medpace Holdings Inc Quarterly Net profit?

Medpace Holdings Inc Quarterly Net profit rose 49.45% YoY to $117.02 M. Its sector's average net profit growth YoY for the quarter was -51.46%.

What is Medpace Holdings Inc Debt to Equity Ratio?

Medpace Holdings Inc Debt to Equity Ratio of 0.15 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Medpace Holdings Inc Return on Equity(ROE)?

Medpace Holdings Inc Return on Equity(ROE) for the last financial year was 58.41%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Medpace Holdings Inc Mutual Fund Holding?

Medpace Holdings Inc Mutual Fund Holding increased by 0.83% in the last quarter to 63.12.

What is Medpace Holdings Inc Promoter Share Holding?

Medpace Holdings Inc Promoter Share Holding increased by 1% in the most recent quarter to 3.23%.

What is Medpace Holdings Inc Institutional Holding?

Medpace Holdings Inc Institutional Holding increased by 0.27% in the last quarter to 85.18.

How is the Medpace Holdings Inc today?

The Medpace Holdings Inc today is trading in the down by -2.46% at 288.99.

How has Medpace Holdings Inc performed historically?

The Medpace Holdings Inc is currently trading down -2.46% on an intraday basis in the past week the index fell -5.34%. The index has been down -16.84% in the past quarter and fell -22.31% in the past year. You can view this in the overview section.

Medpace Holdings Inc XNAS: MEDP

Medpace Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: Medpace Holdings Inc: Is Infosys Ltd. worth buying?
Item: Medpace Holdings Inc
Rating: 2.545347125
Author: Trendlyne DVM scores

Expensive Performer

Download real time

288.99 -7.29 (-2.46%)

37.14% Fall from 52W High

1.2M XNAS Volume

XNAS 21 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Medpace Holdings Inc is on 23 Apr 2025 for the purpose of Medpace Holdings Inc First Quarter Earnings Conference Call for 2025 See details

Medpace Holdings Inc Key Metrics

My Metrics

Default

Market Capitalization High in industry Unavailable in chosen country	8,735.7
PE TTM Below industry Median Unavailable in chosen country	21.6
PEG TTM High in industry Unavailable in chosen country	0.5
Price to Book High in industry Unavailable in chosen country	10.6
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	85.2
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	7.7
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	11.8
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	49.5
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	43
Operating Profit Margin Qtr % High in industry Unavailable in chosen country	23.4
Operating Profit Margin TTM % High in industry Unavailable in chosen country	21.2
Piotroski Score Below industry Median Unavailable in chosen country	6
Rel Perf vs Sector quarter% Unavailable in chosen country	-11.5
ROE Annual % High in industry Unavailable in chosen country	58.4
RoA Annual % High in industry Unavailable in chosen country	21.5

All financials are in USD Million and price data in USD

High Financial Strength

72.2 / 100

Expensive Valuation

21.8 / 100

Technically Neutral

37.4 / 100

Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

327

1Yr Price target upside is 13%

11 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Strong Buy Zone

2.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Medpace Holdings Inc Stock Price Analysis

Day Price Range -2.5% 1 Day return Unavailable in chosen country	289 (LTP) 285296.5 LowHigh
Week Price Range -5.3% 1 Week return Unavailable in chosen country	289 (LTP) 285307 LowHigh
Month Price Range -10.9% 1 Month return Unavailable in chosen country	289 (LTP) 272331.2 LowHigh
52 Week Price Range -22.3% 1 Year return Unavailable in chosen country	289 (LTP) 272459.8 LowHigh

View full Share Price History

Medpace Holdings Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Medpace Holdings Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

12.6

Avg. Estimate

12.4

Low Estimate

12.1

High Estimate

12.9

Current EPS

Avg. Estimate

Miss

EPS is expected to reduce by 2.1% in FY25

Consensus Recommendation

12 ANALYST Recommendations

HOLD

The consensus recommendation from 12 analysts for Medpace Holdings Inc is HOLD

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Medpace Holdings Inc Stock Analysis

Medpace Holdings Inc stock analysis with key metrics, changes, and trends.

Medpace Holdings Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$2,109.05 M	11.84%	positive	Annual Revenue rose 11.84%, in the last year to $2,109.05 M. Its sector's average revenue growth for the last fiscal year was 1.09%.
Annual Net Profit	$404.39 M	42.99%	positive	Annual Net Profit rose 42.99% in the last year to $404.39 M. Its sector's average net profit growth for the last fiscal year was -17.35%.
Price to Earning Ratio	21.6	-	positive	Price to Earning Ratio is 21.6, lower than its sector PE ratio of 29.66.
Stock Price	$288.99	-22.31%	negative	Stock Price fell 22.31% and underperformed its sector by 32.33% in the past year.
Quarterly Revenue	$536.59 M	7.66%	positive	Quarterly Revenue rose 7.66% YoY to $536.59 M. Its sector's average revenue growth YoY for the quarter was 3.41%.
Quarterly Net profit	$117.02 M	49.45%	positive	Quarterly Net profit rose 49.45% YoY to $117.02 M. Its sector's average net profit growth YoY for the quarter was -51.46%.
Debt to Equity Ratio	0.15	-	positive	Debt to Equity Ratio of 0.15 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	58.41 %	58.41%	positive	Return on Equity(ROE) for the last financial year was 58.41%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
Mutual Fund Holding	63.12 %	0.83%	positive	Mutual Fund Holding increased by 0.83% in the last quarter to 63.12.
Promoter Share Holding	3.23 %	1%	positive	Promoter Share Holding increased by 1% in the most recent quarter to 3.23%.
Institutional Holding	85.18 %	0.27%	positive	Institutional Holding increased by 0.27% in the last quarter to 85.18.

VIEW LESS

Loading data..

Medpace Holdings Inc - Company Profile

What does Medpace Holdings Inc do?

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

179.92 K

2024

Gross Remuneration

Year

Medpace Holdings Inc Live Share Price Today, Share Analysis and Chart

37.14% Fall from 52W High

Medpace Holdings Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Medpace Holdings Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Medpace Holdings Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Medpace Holdings Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to reduce by 2.1% in FY25

Consensus Recommendation

The consensus recommendation from 12 analysts for Medpace Holdings Inc is HOLD

Medpace Holdings Inc Stock Analysis

Medpace Holdings Inc stock analysis with key metrics, changes, and trends.

Annual Revenue rose 11.84%, in the last year to $2,109.05 M. Its sector's average revenue growth for the last fiscal year was 1.09%.

Annual Net Profit rose 42.99% in the last year to $404.39 M. Its sector's average net profit growth for the last fiscal year was -17.35%.

Price to Earning Ratio is 21.6, lower than its sector PE ratio of 29.66.

Stock Price fell 22.31% and underperformed its sector by 32.33% in the past year.

Quarterly Revenue rose 7.66% YoY to $536.59 M. Its sector's average revenue growth YoY for the quarter was 3.41%.

Quarterly Net profit rose 49.45% YoY to $117.02 M. Its sector's average net profit growth YoY for the quarter was -51.46%.

Debt to Equity Ratio of 0.15 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 58.41%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 0.83% in the last quarter to 63.12.

Promoter Share Holding increased by 1% in the most recent quarter to 3.23%.

Institutional Holding increased by 0.27% in the last quarter to 85.18.

Medpace Holdings Inc - Company Profile

What does Medpace Holdings Inc do?

Medpace Holdings Inc Management structure

Mr. August J. Troendle, M.D.

Chief Executive Officer and Chairman of the Board

Ms. Susan E Burwig

Executive Vice President, Operations

Mr. Jesse J Geiger

President

Mr. Stephen P Ewald

General Counsel and Corporate Secretary

Mr. Kevin M. Brady

Chief Financial Officer, Treasurer and Principle Accounting Officer

Medpace Holdings Inc Board of directors

Mr. Fred B. Davenport,Jr

Lead Independent Director

Mr. Brian T Carley

Independent Director